Gut bacteria study in ICU patients
Part of Infections clinical trials.
This study looks at certain drug-resistant bacteria in the gut of ICU patients. It aims to understand how common these bacteria are and may help guide future infection control efforts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are expected to stay in the ICU for at least 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how germs that resist certain antibiotics spread in the intensive care unit. It tests if the amount of these germs in a patient's body is linked to how much the room gets contaminated and how easily it infects others.
This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.
This study will track how certain hard-to-treat bacteria spread and cause infections in people who are in the intensive care unit (ICU) or have had a stem cell transplant. The goal is to better understand and prevent these infections in vulnerable patients.
This study looks at how bacteria in the lungs become resistant to antibiotics. It may help doctors choose better treatments for people with serious lung infections in the intensive care unit.
This study looks at bacteria (including antibiotic-resistant germs) present when you are admitted to a hospital. It may help doctors understand how often these germs are carried and how to respond early to prevent spread.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
Hear when a new Rate of Carbapenemase Intestinal Carrier Inside ICU trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.